 Michael Cripps
Concepts (346)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 8 | 2023 | 51 | 3.930 |
Why?
| | Cholecystitis, Acute | 7 | 2024 | 23 | 2.950 |
Why?
| | Wounds and Injuries | 15 | 2025 | 711 | 2.400 |
Why?
| | Cholecystitis | 5 | 2023 | 23 | 2.180 |
Why?
| | Venous Thromboembolism | 5 | 2023 | 284 | 1.690 |
Why?
| | Severity of Illness Index | 7 | 2024 | 2740 | 1.410 |
Why?
| | Trauma Centers | 13 | 2025 | 402 | 1.360 |
Why?
| | Appendicitis | 4 | 2020 | 125 | 1.300 |
Why?
| | Anticoagulants | 5 | 2023 | 636 | 1.190 |
Why?
| | Emergency Treatment | 2 | 2020 | 111 | 1.190 |
Why?
| | Hemorrhage | 8 | 2024 | 678 | 1.080 |
Why?
| | Postoperative Complications | 6 | 2021 | 2473 | 1.040 |
Why?
| | Cholecystectomy | 4 | 2024 | 59 | 0.990 |
Why?
| | Retrospective Studies | 37 | 2025 | 14461 | 0.950 |
Why?
| | Appendectomy | 3 | 2020 | 76 | 0.860 |
Why?
| | Resuscitation | 8 | 2024 | 236 | 0.820 |
Why?
| | Burns | 4 | 2023 | 286 | 0.780 |
Why?
| | Simulation Training | 2 | 2022 | 81 | 0.770 |
Why?
| | Injury Severity Score | 12 | 2025 | 509 | 0.750 |
Why?
| | Adult | 44 | 2025 | 35495 | 0.730 |
Why?
| | Time-to-Treatment | 2 | 2020 | 179 | 0.730 |
Why?
| | Abdomen | 2 | 2018 | 117 | 0.720 |
Why?
| | Prospective Studies | 19 | 2025 | 7123 | 0.710 |
Why?
| | Rib Fractures | 1 | 2021 | 32 | 0.700 |
Why?
| | Machine Learning | 2 | 2023 | 442 | 0.700 |
Why?
| | Middle Aged | 39 | 2025 | 31090 | 0.690 |
Why?
| | Operative Time | 6 | 2023 | 124 | 0.690 |
Why?
| | Artificial Intelligence | 1 | 2023 | 246 | 0.680 |
Why?
| | Pain Management | 2 | 2021 | 324 | 0.680 |
Why?
| | Shock, Hemorrhagic | 5 | 2024 | 165 | 0.680 |
Why?
| | Nerve Block | 1 | 2021 | 65 | 0.670 |
Why?
| | Emergency Medical Services | 2 | 2023 | 521 | 0.670 |
Why?
| | Critical Pathways | 1 | 2021 | 80 | 0.670 |
Why?
| | Enoxaparin | 3 | 2023 | 59 | 0.660 |
Why?
| | Length of Stay | 7 | 2021 | 1120 | 0.660 |
Why?
| | Blood Coagulation | 2 | 2018 | 238 | 0.650 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 336 | 0.650 |
Why?
| | Thrombelastography | 3 | 2021 | 150 | 0.640 |
Why?
| | Humans | 78 | 2025 | 129266 | 0.630 |
Why?
| | Specialties, Surgical | 1 | 2020 | 73 | 0.620 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 164 | 0.620 |
Why?
| | Balloon Occlusion | 3 | 2024 | 34 | 0.620 |
Why?
| | Kaolin | 1 | 2018 | 4 | 0.610 |
Why?
| | Factor Xa | 1 | 2018 | 32 | 0.610 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 41 | 0.610 |
Why?
| | Vitamin K | 1 | 2018 | 41 | 0.600 |
Why?
| | Hemostatics | 1 | 2018 | 49 | 0.580 |
Why?
| | Male | 50 | 2025 | 63512 | 0.580 |
Why?
| | Airway Extubation | 1 | 2018 | 54 | 0.580 |
Why?
| | Embolization, Therapeutic | 3 | 2024 | 206 | 0.580 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 78 | 0.570 |
Why?
| | Laparoscopy | 2 | 2022 | 449 | 0.570 |
Why?
| | Female | 52 | 2025 | 68551 | 0.570 |
Why?
| | Internship and Residency | 4 | 2022 | 1047 | 0.560 |
Why?
| | Atrial Flutter | 1 | 2017 | 35 | 0.550 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 44 | 0.540 |
Why?
| | Appendix | 1 | 2017 | 27 | 0.540 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1004 | 0.520 |
Why?
| | Algorithms | 1 | 2023 | 1613 | 0.500 |
Why?
| | Texas | 5 | 2019 | 228 | 0.490 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 1949 | 0.480 |
Why?
| | Patient Safety | 1 | 2018 | 285 | 0.480 |
Why?
| | Treatment Outcome | 17 | 2024 | 10202 | 0.480 |
Why?
| | Biomedical Research | 1 | 2021 | 637 | 0.480 |
Why?
| | Critical Illness | 2 | 2019 | 757 | 0.480 |
Why?
| | Blood Transfusion | 2 | 2018 | 295 | 0.480 |
Why?
| | Endovascular Procedures | 3 | 2024 | 301 | 0.470 |
Why?
| | Hospitalization | 3 | 2022 | 2052 | 0.430 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 376 | 0.410 |
Why?
| | Mass Screening | 4 | 2023 | 1149 | 0.400 |
Why?
| | Aged | 19 | 2025 | 22032 | 0.400 |
Why?
| | Clinical Competence | 2 | 2022 | 1016 | 0.390 |
Why?
| | Liver | 3 | 2024 | 1839 | 0.370 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 3 | 0.350 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.350 |
Why?
| | Operating Rooms | 3 | 2022 | 115 | 0.320 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3080 | 0.320 |
Why?
| | Risk Assessment | 10 | 2021 | 3232 | 0.320 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 5 | 0.310 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 81 | 0.310 |
Why?
| | Safety-net Providers | 3 | 2019 | 109 | 0.310 |
Why?
| | Emergency Service, Hospital | 5 | 2024 | 1896 | 0.300 |
Why?
| | Abdominal Abscess | 2 | 2020 | 26 | 0.300 |
Why?
| | Geriatric Assessment | 2 | 2020 | 205 | 0.300 |
Why?
| | Logistic Models | 4 | 2024 | 1985 | 0.300 |
Why?
| | Time Factors | 9 | 2020 | 6543 | 0.300 |
Why?
| | Multiple Trauma | 1 | 2009 | 101 | 0.290 |
Why?
| | Hospitals | 2 | 2022 | 630 | 0.280 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 60 | 0.280 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 2 | 2024 | 18 | 0.280 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 49 | 0.280 |
Why?
| | Blood Coagulation Disorders | 2 | 2021 | 167 | 0.280 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 213 | 0.270 |
Why?
| | Aorta | 3 | 2024 | 408 | 0.270 |
Why?
| | Triage | 1 | 2009 | 206 | 0.260 |
Why?
| | Quality Improvement | 4 | 2024 | 1095 | 0.260 |
Why?
| | Choledocholithiasis | 2 | 2015 | 14 | 0.250 |
Why?
| | Young Adult | 10 | 2023 | 12391 | 0.250 |
Why?
| | Cause of Death | 3 | 2017 | 392 | 0.240 |
Why?
| | Facial Bones | 1 | 2025 | 28 | 0.230 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1497 | 0.230 |
Why?
| | Facial Injuries | 1 | 2025 | 18 | 0.230 |
Why?
| | Skull Fractures | 1 | 2025 | 33 | 0.230 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 2 | 0.230 |
Why?
| | Wound Infection | 1 | 2025 | 29 | 0.230 |
Why?
| | Hepatic Artery | 1 | 2024 | 59 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 5 | 2024 | 2515 | 0.230 |
Why?
| | Hematoma | 1 | 2024 | 53 | 0.220 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 101 | 0.220 |
Why?
| | Registries | 4 | 2024 | 1895 | 0.210 |
Why?
| | Adolescent | 7 | 2023 | 20313 | 0.210 |
Why?
| | Venous Thrombosis | 1 | 2025 | 175 | 0.210 |
Why?
| | ROC Curve | 2 | 2022 | 503 | 0.190 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 5384 | 0.190 |
Why?
| | Health Plan Implementation | 2 | 2020 | 137 | 0.190 |
Why?
| | Time Perception | 1 | 2022 | 28 | 0.190 |
Why?
| | Aged, 80 and over | 5 | 2020 | 7055 | 0.190 |
Why?
| | Patient Handoff | 1 | 2021 | 30 | 0.190 |
Why?
| | General Surgery | 2 | 2020 | 152 | 0.190 |
Why?
| | Pelvic Bones | 1 | 2024 | 156 | 0.180 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 13 | 0.180 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 239 | 0.180 |
Why?
| | Wounds, Nonpenetrating | 1 | 2024 | 271 | 0.180 |
Why?
| | Liver Failure, Acute | 1 | 2021 | 64 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1365 | 0.180 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 110 | 0.180 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 104 | 0.180 |
Why?
| | Altitude | 1 | 2025 | 462 | 0.180 |
Why?
| | Anesthetics, Local | 1 | 2021 | 75 | 0.170 |
Why?
| | Risk Factors | 7 | 2024 | 9745 | 0.170 |
Why?
| | Bias | 1 | 2021 | 196 | 0.170 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 35 | 0.170 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2021 | 132 | 0.170 |
Why?
| | Laparotomy | 1 | 2020 | 106 | 0.170 |
Why?
| | United States Social Security Administration | 1 | 2019 | 2 | 0.170 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.170 |
Why?
| | Ileus | 1 | 2019 | 12 | 0.160 |
Why?
| | Mycoses | 1 | 2020 | 71 | 0.160 |
Why?
| | Loperamide | 1 | 2019 | 11 | 0.160 |
Why?
| | Metoclopramide | 1 | 2019 | 19 | 0.160 |
Why?
| | Erythromycin | 1 | 2019 | 24 | 0.160 |
Why?
| | Antifungal Agents | 1 | 2020 | 129 | 0.160 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 15 | 0.160 |
Why?
| | Diet Therapy | 1 | 2019 | 34 | 0.160 |
Why?
| | Violence | 2 | 2023 | 239 | 0.160 |
Why?
| | Surgicenters | 1 | 2019 | 6 | 0.160 |
Why?
| | Abdominal Injuries | 1 | 2020 | 118 | 0.160 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 8 | 0.160 |
Why?
| | Fractures, Bone | 1 | 2024 | 392 | 0.160 |
Why?
| | Glasgow Coma Scale | 2 | 2024 | 165 | 0.150 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 10 | 0.150 |
Why?
| | Hospitals, University | 1 | 2019 | 179 | 0.150 |
Why?
| | Dabigatran | 1 | 2018 | 21 | 0.150 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 58 | 0.150 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 15 | 0.150 |
Why?
| | Program Evaluation | 2 | 2020 | 872 | 0.150 |
Why?
| | Publishing | 1 | 2020 | 140 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 146 | 0.150 |
Why?
| | Pipecolic Acids | 1 | 2018 | 25 | 0.150 |
Why?
| | Bandages | 1 | 2018 | 32 | 0.150 |
Why?
| | Diarrhea | 1 | 2019 | 180 | 0.150 |
Why?
| | Photoperiod | 1 | 2018 | 46 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 341 | 0.150 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 283 | 0.150 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 133 | 0.150 |
Why?
| | Antithrombins | 1 | 2018 | 58 | 0.150 |
Why?
| | Hospital Mortality | 5 | 2020 | 846 | 0.140 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 108 | 0.140 |
Why?
| | Myocardial Contusions | 1 | 2017 | 1 | 0.140 |
Why?
| | Emergencies | 1 | 2018 | 155 | 0.140 |
Why?
| | Enteral Nutrition | 1 | 2019 | 188 | 0.140 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 244 | 0.140 |
Why?
| | Thorax | 1 | 2017 | 41 | 0.140 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 33 | 0.140 |
Why?
| | Patient Transfer | 1 | 2019 | 148 | 0.140 |
Why?
| | Accidental Falls | 1 | 2020 | 169 | 0.140 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 71 | 0.140 |
Why?
| | Tachycardia | 1 | 2017 | 57 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2017 | 50 | 0.140 |
Why?
| | Police | 1 | 2017 | 36 | 0.140 |
Why?
| | Smartphone | 1 | 2018 | 87 | 0.140 |
Why?
| | Cohort Studies | 3 | 2020 | 5409 | 0.140 |
Why?
| | Blood Viscosity | 1 | 2016 | 16 | 0.140 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1708 | 0.130 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 170 | 0.130 |
Why?
| | Pelvis | 1 | 2017 | 104 | 0.130 |
Why?
| | Photography | 1 | 2017 | 93 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 265 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 253 | 0.130 |
Why?
| | Occupational Injuries | 1 | 2017 | 45 | 0.130 |
Why?
| | Research Design | 1 | 2023 | 1043 | 0.130 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 291 | 0.130 |
Why?
| | United States | 10 | 2025 | 13826 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 569 | 0.130 |
Why?
| | Rivaroxaban | 1 | 2018 | 252 | 0.130 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 93 | 0.130 |
Why?
| | Critical Care | 1 | 2021 | 551 | 0.130 |
Why?
| | Radiography, Interventional | 1 | 2016 | 105 | 0.130 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 79 | 0.130 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 231 | 0.120 |
Why?
| | Blood Safety | 1 | 2015 | 10 | 0.120 |
Why?
| | Platelet Transfusion | 1 | 2016 | 59 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 204 | 0.120 |
Why?
| | Medical Marijuana | 1 | 2017 | 111 | 0.120 |
Why?
| | Cryopreservation | 1 | 2015 | 92 | 0.110 |
Why?
| | Sulfonamides | 1 | 2018 | 495 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 442 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 438 | 0.110 |
Why?
| | Benchmarking | 1 | 2015 | 176 | 0.110 |
Why?
| | Watchful Waiting | 2 | 2024 | 67 | 0.110 |
Why?
| | Exsanguination | 1 | 2013 | 19 | 0.110 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 181 | 0.110 |
Why?
| | Angiography | 2 | 2024 | 196 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 174 | 0.100 |
Why?
| | Burn Units | 3 | 2019 | 42 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1497 | 0.100 |
Why?
| | Patient Discharge | 1 | 2019 | 835 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 327 | 0.100 |
Why?
| | Chronic Pain | 1 | 2017 | 252 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2016 | 395 | 0.100 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 47 | 0.090 |
Why?
| | Blood Preservation | 1 | 2015 | 271 | 0.090 |
Why?
| | Age Factors | 5 | 2020 | 3140 | 0.090 |
Why?
| | Suicide | 1 | 2018 | 580 | 0.090 |
Why?
| | Child Abuse | 1 | 2016 | 511 | 0.090 |
Why?
| | Propensity Score | 2 | 2025 | 263 | 0.080 |
Why?
| | Surgical Mesh | 1 | 2010 | 46 | 0.080 |
Why?
| | Malaria | 1 | 2010 | 59 | 0.080 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 26 | 0.080 |
Why?
| | Brain Injuries | 1 | 2014 | 466 | 0.080 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 10 | 0.080 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.080 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 78 | 0.080 |
Why?
| | Survival Rate | 3 | 2020 | 1869 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4887 | 0.080 |
Why?
| | Capillary Permeability | 1 | 2009 | 140 | 0.080 |
Why?
| | Acute Disease | 2 | 2023 | 978 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1018 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1266 | 0.070 |
Why?
| | Delivery of Health Care | 1 | 2014 | 892 | 0.070 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 206 | 0.060 |
Why?
| | Ultrasonography | 2 | 2023 | 713 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1199 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2719 | 0.060 |
Why?
| | Radiology, Interventional | 1 | 2024 | 30 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2024 | 114 | 0.050 |
Why?
| | Comorbidity | 2 | 2019 | 1544 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 17 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 45 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 2 | 1982 | 63 | 0.050 |
Why?
| | Hypoxia | 1 | 2009 | 1084 | 0.050 |
Why?
| | Delphi Technique | 1 | 2023 | 225 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5050 | 0.050 |
Why?
| | Contrast Media | 1 | 2024 | 393 | 0.050 |
Why?
| | Incidence | 2 | 2018 | 2636 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 87 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 615 | 0.040 |
Why?
| | Antidiarrheals | 1 | 2019 | 15 | 0.040 |
Why?
| | Data Collection | 1 | 2022 | 647 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 232 | 0.040 |
Why?
| | Educational Measurement | 1 | 2022 | 260 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 83 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 60 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 57 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 136 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 138 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 98 | 0.040 |
Why?
| | Acetaminophen | 1 | 2021 | 246 | 0.040 |
Why?
| | Infant | 4 | 2023 | 8975 | 0.040 |
Why?
| | Growth Disorders | 1 | 1979 | 80 | 0.040 |
Why?
| | Hospital Costs | 1 | 2019 | 114 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 3773 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2019 | 139 | 0.040 |
Why?
| | Child, Preschool | 4 | 2023 | 10459 | 0.040 |
Why?
| | Leadership | 1 | 2022 | 353 | 0.040 |
Why?
| | California | 1 | 2019 | 400 | 0.040 |
Why?
| | Military Personnel | 1 | 2024 | 515 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 199 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2017 | 137 | 0.030 |
Why?
| | Homicide | 1 | 2017 | 60 | 0.030 |
Why?
| | Probability | 1 | 2017 | 305 | 0.030 |
Why?
| | Burns, Chemical | 1 | 2016 | 29 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2017 | 184 | 0.030 |
Why?
| | Counseling | 1 | 2019 | 383 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 194 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 613 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 504 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 120 | 0.030 |
Why?
| | Biliary Tract | 1 | 2015 | 15 | 0.030 |
Why?
| | Communication | 1 | 2021 | 836 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 60 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 40 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 203 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 372 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 112 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2019 | 526 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 793 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 129 | 0.030 |
Why?
| | Risk | 1 | 2017 | 854 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1584 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 420 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 506 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 290 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1197 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1269 | 0.030 |
Why?
| | India | 1 | 2014 | 170 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2014 | 254 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2553 | 0.030 |
Why?
| | Guatemala | 1 | 2014 | 313 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1288 | 0.020 |
Why?
| | International Normalized Ratio | 1 | 2012 | 46 | 0.020 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 52 | 0.020 |
Why?
| | Platelet Count | 1 | 2012 | 82 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 262 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 82 | 0.020 |
Why?
| | Child | 3 | 2023 | 20785 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3386 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 1965 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1875 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 765 | 0.020 |
Why?
| | Venules | 1 | 2009 | 14 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 37 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 38 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 278 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2630 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 6390 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2396 | 0.010 |
Why?
| | Luteinizing Hormone | 2 | 1982 | 178 | 0.010 |
Why?
| | Growth | 1 | 1982 | 58 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 2 | 1982 | 235 | 0.010 |
Why?
| | Aneuploidy | 1 | 1982 | 92 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1212 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5482 | 0.010 |
Why?
| | Y Chromosome | 1 | 1979 | 8 | 0.010 |
Why?
| | X Chromosome | 1 | 1979 | 52 | 0.010 |
Why?
| | Bone Development | 1 | 1979 | 50 | 0.010 |
Why?
| | Child Development | 1 | 1982 | 457 | 0.010 |
Why?
| | Intellectual Disability | 1 | 1979 | 154 | 0.010 |
Why?
| | Infant, Newborn | 2 | 1982 | 5736 | 0.010 |
Why?
| | Animals | 1 | 2009 | 35309 | 0.000 |
Why?
| | Psychology, Child | 1 | 1982 | 36 | 0.000 |
Why?
| | Sexual Maturation | 1 | 1982 | 52 | 0.000 |
Why?
| | Body Height | 1 | 1982 | 192 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1982 | 131 | 0.000 |
Why?
| | Body Weight | 1 | 1982 | 939 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1982 | 2715 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|